xaciato
Generic: clindamycin phosphate
xaciato: developed by 3 companies. Updated within the last hour.
Development Pipeline (3)
| Company | Phase |
|---|---|
| Dare Bioscience, Inc. (DARE) | Approved |
| Organon & Co. (OGN) | Approved |
| XOMA Royalty Corporation (XOMA) | — |
Get deeper analysis on xaciato
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis